Clinical Trials Directory

Trials / Completed

CompletedNCT00471861

Inflammatory Markers in Patients With Active Migraine Headaches

Does Migraine As A Partly Inflammatory Disease Increase The Inflammatory Markers Of The Patient When Actively Having a Migraine?

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Westside Family Medical Center, P.C. · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.

Detailed description

A random selection of patients both male and female from a primary care practice with a diagnosis of having migraine headaches will be enrolled. Thirty (30) patients will be recruited mainly from the primary care practice. Recruitment will include males and females aged 21-65. The patients who meet the inclusion criteria will be enrolled. The patients who do not have migraine headaches will also be enrolled and function as controls. Non-migraine patients will meet inclusion criteria 1, 2 and 3 and all of the exclusion criteria.

Conditions

Timeline

Start date
2007-05-01
Completion
2009-02-01
First posted
2007-05-10
Last updated
2011-08-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00471861. Inclusion in this directory is not an endorsement.

Inflammatory Markers in Patients With Active Migraine Headaches (NCT00471861) · Clinical Trials Directory